BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1157 related articles for article (PubMed ID: 23993972)

  • 1. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.
    Ogino T; Nishimura J; Barman S; Kayama H; Uematsu S; Okuzaki D; Osawa H; Haraguchi N; Uemura M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Takeda K; Doki Y; Mori M
    Gastroenterology; 2013 Dec; 145(6):1380-91.e1. PubMed ID: 23993972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased production of retinoic acid by intestinal macrophages contributes to their inflammatory phenotype in patients with Crohn's disease.
    Sanders TJ; McCarthy NE; Giles EM; Davidson KL; Haltalli ML; Hazell S; Lindsay JO; Stagg AJ
    Gastroenterology; 2014 May; 146(5):1278-88.e1-2. PubMed ID: 24503130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a human intestinal myeloid cell subset that regulates gut homeostasis.
    Barman S; Kayama H; Okuzaki D; Ogino T; Osawa H; Matsuno H; Mizushima T; Mori M; Nishimura J; Takeda K
    Int Immunol; 2016 Nov; 28(11):533-545. PubMed ID: 27421871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.
    Liu Z; Yadav PK; Xu X; Su J; Chen C; Tang M; Lin H; Yu J; Qian J; Yang PC; Wang X
    J Leukoc Biol; 2011 Apr; 89(4):597-606. PubMed ID: 21227898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-12 and Mucosal CD14+ Monocyte-Like Cells Induce IL-8 in Colonic Memory CD4+ T Cells of Patients With Ulcerative Colitis but not Crohn's Disease.
    Chapuy L; Bsat M; Rubio M; Sarkizova S; Therrien A; Bouin M; Orlicka K; Weber A; Soucy G; Villani AC; Sarfati M
    J Crohns Colitis; 2020 Jan; 14(1):79-95. PubMed ID: 31206576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human CD14+ macrophages in intestinal lamina propria exhibit potent antigen-presenting ability.
    Kamada N; Hisamatsu T; Honda H; Kobayashi T; Chinen H; Kitazume MT; Takayama T; Okamoto S; Koganei K; Sugita A; Kanai T; Hibi T
    J Immunol; 2009 Aug; 183(3):1724-31. PubMed ID: 19592647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
    Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H
    Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells.
    Chinen H; Matsuoka K; Sato T; Kamada N; Okamoto S; Hisamatsu T; Kobayashi T; Hasegawa H; Sugita A; Kinjo F; Fujita J; Hibi T
    Gastroenterology; 2007 Aug; 133(2):559-73. PubMed ID: 17681176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163.
    Demetter P; De Vos M; Van Huysse JA; Baeten D; Ferdinande L; Peeters H; Mielants H; Veys EM; De Keyser F; Cuvelier CA
    Ann Rheum Dis; 2005 Feb; 64(2):321-4. PubMed ID: 15166002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease.
    Franzè E; Caruso R; Stolfi C; Sarra M; Cupi ML; Caprioli F; Monteleone I; Zorzi F; De Nitto D; Colantoni A; Biancone L; Pallone F; Monteleone G
    PLoS One; 2013; 8(7):e69839. PubMed ID: 23922818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced numbers of mucosal DR(int) macrophages and increased numbers of CD103(+) dendritic cells during anti-TNF-α treatment in patients with Crohn's disease.
    Dige A; Magnusson MK; Öhman L; Hvas CL; Kelsen J; Wick MJ; Agnholt J
    Scand J Gastroenterol; 2016; 51(6):692-9. PubMed ID: 26784676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate Myeloid Cell Subset-Specific Gene Expression Patterns in the Human Colon are Altered in Crohn's Disease Patients.
    Sekido Y; Yasumizu Y; Nishimura J; Kayama H; Matsuno H; Ogino T; Miyoshi N; Takahashi H; Haraguchi N; Hata T; Matsuda C; Doki Y; Mori M; Takeda K; Ohkura N; Sakaguchi S; Mizushima T
    Digestion; 2019; 99(3):194-204. PubMed ID: 30343293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.
    Takayama T; Kamada N; Chinen H; Okamoto S; Kitazume MT; Chang J; Matuzaki Y; Suzuki S; Sugita A; Koganei K; Hisamatsu T; Kanai T; Hibi T
    Gastroenterology; 2010 Sep; 139(3):882-92, 892.e1-3. PubMed ID: 20638936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophages.
    Atreya R; Zimmer M; Bartsch B; Waldner MJ; Atreya I; Neumann H; Hildner K; Hoffman A; Kiesslich R; Rink AD; Rau TT; Rose-John S; Kessler H; Schmidt J; Neurath MF
    Gastroenterology; 2011 Dec; 141(6):2026-38. PubMed ID: 21875498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
    Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
    Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease.
    Sakuraba A; Sato T; Kamada N; Kitazume M; Sugita A; Hibi T
    Gastroenterology; 2009 Nov; 137(5):1736-45. PubMed ID: 19632232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
    Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
    Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine expression in intestinal mucosal biopsies. In situ hybridisation of the mRNA for interleukin-1 beta, interleukin-6 and tumour necrosis factor-alpha in inflammatory bowel disease.
    Woywodt A; Neustock P; Kruse A; Schwarting K; Ludwig D; Stange EF; Kirchner H
    Eur Cytokine Netw; 1994; 5(4):387-95. PubMed ID: 7841354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.